Literature DB >> 4448315

Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.

J Pirotte, J M Guffens, J Devos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4448315     DOI: 10.1159/000197556

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


× No keyword cloud information.
  7 in total

Review 1.  Lactulose: a review of its therapeutic and pharmacological properties with particular reference to ammonia metabolism and its mode of action of portal systemic encephalopathy.

Authors:  G S Avery; E F Davies; R N Brogden
Journal:  Drugs       Date:  1972       Impact factor: 9.546

2.  Interactions of lactulose and neomycin.

Authors:  H O Conn
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 3.  Progress in the treatment of chronic portasystemic encephalopathy.

Authors:  I R Crossley; R Williams
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

Review 4.  Pathophysiology and clinical basis of prevention and treatment of complications of chronic liver disease.

Authors:  S Wagner; H U Lautz; M J Müller; F W Schmidt
Journal:  Klin Wochenschr       Date:  1991-02-06

5.  Effects of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis.

Authors:  H Miyaji; S Ito; T Azuma; Y Ito; Y Yamazaki; Y Ohtaki; F Sato; M Hirai; M Kuriyama; Y Kohli
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

6.  Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial.

Authors:  C E Atterbury; W C Maddrey; H O Conn
Journal:  Am J Dig Dis       Date:  1978-05

Review 7.  Use Of Quantitative Modelling To Elucidate The Roles Of The Liver, Gut, Kidney, And Muscle In Ammonia Homeostasis And How Lactulose And Rifaximin Alter This Homeostasis.

Authors:  Michael D Levitt; David G Levitt
Journal:  Int J Gen Med       Date:  2019-10-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.